Search This Blog

Tuesday, December 18, 2018

Adamas Pharma nabs new U.S. patent for Gocovri


The USPTO has issued a new method-of-use patent to Adamas Pharmaceuticals (NASDAQ:ADMS) covering GOCOVRI (amantadine) extended-release capsules. Specifically, the patent claims a method of reducing OFF time in Parkinson’s disease patients.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)